2022
DOI: 10.1016/j.jtcvs.2021.10.045
|View full text |Cite
|
Sign up to set email alerts
|

Neuregulin-1 enhances cell-cycle activity, delays cardiac fibrosis, and improves cardiac performance in rat pups with right ventricular pressure load

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 34 publications
1
5
0
Order By: Relevance
“…After birth, cardiomyocyte proliferation capacity is lost in mammals as a result of several postnatal processes, such as changes in oxygen levels and the transition from placental to enteral nutrition ( 91 ). However, recent studies have shown that cardiomyocytes retain the potential to proliferate after birth when under stress ( 12 , 92 ).…”
Section: Histopathology: What Do We Know?mentioning
confidence: 99%
See 3 more Smart Citations
“…After birth, cardiomyocyte proliferation capacity is lost in mammals as a result of several postnatal processes, such as changes in oxygen levels and the transition from placental to enteral nutrition ( 91 ). However, recent studies have shown that cardiomyocytes retain the potential to proliferate after birth when under stress ( 12 , 92 ).…”
Section: Histopathology: What Do We Know?mentioning
confidence: 99%
“…Cardiomyocyte proliferation promotes adaptation to pressure overload better than cellular hypertrophy ( 92 95 ). Stimulating proliferation in mature cardiomyocytes or prolonging proliferative capacity after birth is therefore an attractive treatment target to preserve function of the overloaded RV.…”
Section: Histopathology: What Do We Know?mentioning
confidence: 99%
See 2 more Smart Citations
“…RT-qPCR of specific genes (26)(27)(28)(29) representing cardiomyocyte stress [natriuretic peptide B (NPPB)], fetal gene switch [myosin heavy chain 7 (MYH7) to myosin heavy chain 6 (MYH6) ratio], profibrotic signaling [TIMP metallopeptidase inhibitor 1 (TIMP1)] and pathological hypertrophy [regulator of calcineurin (RCAN)1] were measured as described previously (30). Expression data were corrected for the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by means of the DDCT method.…”
Section: Gene Expression In Rv Tissuementioning
confidence: 99%